Top Stories
-
At Columbia, patients with brain cancer will be able to participate in a new type of clinical trial that promises to speed up the development of better drugs for glioblastoma.
Topic
-
Fewer than 1 in 10 patients with glioblastoma—the most common type of brain cancer—respond to immunotherapy; a new study reveals how to detect patients who may respond.
Topic
-
Though far from the most common form of cancer, brain cancers are uniquely difficult to treat. Columbia scientists are researching multiple new ways to attack the tumors.
Topic
-
The fusion of two adjacent genes can cause cancer by kicking mitochondria into overdrive and increasing the amount of fuel available for rampant cell growth.
Topic
Latest News
- November 15, 2012
Link between kidney defects and neurodevelopmental delays in kids
Topic
- July 30, 2012
A common & aggressive brain cancer appears to be caused by a genetic mutation -- and targeting it with a drug showed promise in mice.
Topic
- July 26, 2012
Some cases of glioblastoma, the most common & aggressive form of brain cancer, are caused by the fusion of 2 adjacent genes.
Topic
-
-
